Investment
CroíValve lands additional $27M for expanded TANDEM II study
CroíValve, a clinical-stage medical device company developing a transcatheter solution for tricuspid regurgitation (TR), has announced the completion of a $20 million Series B expansion financing...
Wed, 24 Jun 2026
